Clik here to view.
Merck Shows Off Bevy of New Drugs
Image by Chemical Heritage Foundation via Flickr While Merck’s net profits might be a little low in the wake of the Schering-Plough merger, it’s pipeline—and future sales—are far from bleak. According...
View ArticleClik here to view.
With Cannabis, Science Trumps Culture, Says GW Pharma CEO
Already approved in 22 countries, GW Pharma’s Sativex product, if approved by FDA, would become the first prescription drug derived from raw cannabis to enter the US market. In the last several years,...
View ArticleClik here to view.
Ever Bullish, Al Mann Says Afrezza is Coming in Mid-April
Alfred Mann, founder and CEO, MannKind Post Exubera, inhaled insulin has been an uphill struggle with regulators. Alfred Mann and MannKind are nonetheless determined to push Afrezza, an ”ultra”...
View ArticleSanofi Reports Progress Toward First Dengue Vaccine
Sanofi Pasteur, the vaccines division of Sanofi, reports that results of an efficacy study is a step closer to making dengue the next vaccine-preventable disease. Sanofi points to The Lancet’s...
View Article
